Market Cap: $904.56M
Market Cap: $904.56M

Artivion, Inc. (Ticker: AORT) receives FDA approval for its AMDS Hybrid Prosthesis, a significant development in the treatment of acute Debakey Type I aortic dissections with malperfusion. This innova…

Artivion (Ticker: AORT) addresses a critical juncture in its growth narrative against the backdrop of its latest financial report. Revenue Growth Amid Profitability Concerns The company experiences a…
Artivion, Inc. (Ticker: AORT) has reported significant achievements alongside notable challenges following its latest financial disclosures. In the first quarter of 2026, the company showcases a reven…

In a significant advancement within the cardiovascular device sector, Artivion, Inc. receives FDA approval for the Premarket Approval (PMA) of the NEXUS Aortic Arch System, developed by Endospan. This…

Artivion makes significant strides in aortic disease treatment with the FDA's recent approval of its NEXUS Aortic Arch System. This innovative technology is pivotal for patients suffering from aortic…
Artivion, Inc. (NYSE: AORT) secures FDA approval for its NEXUS® Aortic Arch System, revolutionizing treatment for aortic arch disease. This approval marks a major advancement in minimally invasive car…
Artivion Insider Sales Surge Raises Questions About Future Direction Artivion, a prominent player in the medical technology sector that specializes in cardiovascular solutions, has recently seen a wav…
Artivion's Insider Sales: An Indicator of Executive Sentiment Amidst Market Scrutiny On March 4, Artivion, Inc. (NYSE: AORT), a prominent player in the medical technology sector, experiences a wave of…
Artivion's Commitment to Innovation in Cardiac Care Artivion continues to demonstrate its dedication to advancing cardiac care through innovative solutions and patient-centric approaches. The company…
Valentine’s Day with a Twist: San Antonio Zoo’s "Cry Me a Cockroach" Fundraiser Returns The San Antonio Zoo revitalizes its unique and humorous Valentine's Day fundraiser, "Cry Me a Cockroach," allowi…
Valentine's Day Takes a Unique Turn with San Antonio Zoo's "Cry Me a Cockroach" Fundraiser As Valentine's Day approaches, the San Antonio Zoo reinvigorates its quirky fundraiser, "Cry Me a Cockroach."…
Artivion's Analysts: Diverse Perspectives on Growth Potential In the latest quarter, Artivion attracts attention from six analysts, each offering a unique perspective on the company’s future in the he…
Artivion Launches Pivotal Trial for Groundbreaking Aortic Treatment Artivion, Inc. (NYSE: AORT), a leader in cardiac and vascular surgery focused on aortic diseases, initiates a significant milestone…
Artivion Advances Cardiac Care with ARTIZEN Trial Artivion, Inc. (NYSE: AORT), a leader in cardiac and vascular surgery focused on aortic diseases, takes a significant step in enhancing treatment opti…
Artivion Showcases Groundbreaking Advances in Aortic Disease Treatment at EACTS Artivion, Inc., a leader in the field of cardiac and vascular surgery, presents impactful findings from its recent AMDS…
Artivion Showcases Groundbreaking AMDS Trial Results at EACTS Annual Meeting Artivion, Inc. (NYSE: AORT), a leader in cardiac and vascular surgery, presents compelling data from its AMDS PERSEVERE and…
Artivion: Pioneering Innovations in Cardiac and Vascular Surgery Artivion, Inc., a leading player in the cardiac and vascular surgery sector, is set to showcase its advancements at the upcoming Morgan…
Artivion Engages with Global Healthcare Community at Upcoming Conference Artivion, Inc., a leading entity in cardiac and vascular surgery dedicated to addressing aortic disease, is set to showcase its…
Artivion Navigates Mixed Analyst Sentiments Amid Strategic Initiatives In the latest quarter, Artivion, Inc. faces a nuanced landscape as four financial analysts evaluate the company’s potential in th…
Artivion's Growth Potential Amid Analyst Divergence In the latest quarter, Artivion, Inc. (AORT) garners attention as a focus of analysis among four financial experts, each offering contrasting opinio…
Artivion Showcases Commitment to Aortic Disease Solutions at Upcoming Conferences Artivion, Inc., a leading player in cardiac and vascular surgical solutions, prepares to highlight its innovative appr…
Artivion Expands Engagement with Investors through Strategic Conference Participation Artivion, Inc., a leader in cardiac and vascular surgical solutions, actively participates in two upcoming investo…
Artivion Strengthens Connections in Cardiac and Vascular Surgery Sector Artivion, Inc., a leading player in cardiac and vascular surgery solutions for aortic diseases, is actively engaging with invest…
Artivion Advances in Cardiac and Vascular Surgery Through Investor Engagements Artivion, Inc., a key player in the field of cardiac and vascular surgery, announces its participation in two important i…
Addressing Veteran Mental Health: A Call for Change in Care Practices The "War Cry For Change" Veteran Harm Reduction Summit, organized by the Grunt Style Foundation in collaboration with the Veterans…
Addressing Veteran Mental Health: A Call to Action In a critical development for veteran mental health, the Grunt Style Foundation, in partnership with the Veterans of Foreign Wars (VFW) and Disabled…
Artivion Advances Aortic Disease Treatment with Promising Clinical Data Artivion, Inc., a leader in cardiac and vascular surgery specializing in aortic disease, showcases significant advancements in t…
Innovative Advances in Aortic Disease Treatment: Artivion's NEXUS TRIOMPHE Trial Findings Artivion, Inc., a leader in cardiac and vascular surgery, makes significant strides in the treatment of aortic…
Artivion Reports Robust Growth Amid FDA Advancements in Cardiac Technology Artivion, Inc., a key player in the cardiac and vascular surgery sector, announces solid financial results for the fourth qua…
Artivion Advances in Cardiac and Vascular Surgery with Promising Financial Results and Innovations Artivion, Inc., a leader in cardiac and vascular surgery, announces its financial results for the fou…
Artivion's Groundbreaking AMDS Trial Results Mark a Milestone in Aortic Disease Treatment Artivion, Inc., a leader in the field of cardiac and vascular surgery, showcases a significant advancement in…
Breakthrough in Aortic Disease Management: Artivion's AMDS PERSEVERE Trial Results Artivion, Inc. has made significant strides in the treatment of aortic diseases with the announcement of positive res…
Artivion Secures FDA HDE for Groundbreaking Aortic Device Artivion, Inc. announces a significant advancement in cardiac and vascular surgery with the recent grant of a Humanitarian Device Exemption (H…
Artivion Drives Growth with Innovative Products and Regulatory Milestones In the third quarter of 2024, Artivion, Inc., a key player in cardiac and vascular surgery with a focus on aortic disease, dem…